U.S. markets closed
  • S&P 500

    4,401.46
    -20.84 (-0.47%)
     
  • Dow 30

    35,058.52
    -85.79 (-0.24%)
     
  • Nasdaq

    14,660.58
    -180.14 (-1.21%)
     
  • Russell 2000

    2,191.83
    -25.09 (-1.13%)
     
  • Crude Oil

    71.98
    +0.33 (+0.46%)
     
  • Gold

    1,799.00
    -0.80 (-0.04%)
     
  • Silver

    24.73
    +0.08 (+0.33%)
     
  • EUR/USD

    1.1820
    +0.0013 (+0.11%)
     
  • 10-Yr Bond

    1.2340
    -0.0420 (-3.29%)
     
  • GBP/USD

    1.3880
    +0.0056 (+0.41%)
     
  • USD/JPY

    109.7730
    -0.6020 (-0.55%)
     
  • BTC-USD

    39,216.02
    +1,784.07 (+4.77%)
     
  • CMC Crypto 200

    898.78
    +22.55 (+2.57%)
     
  • FTSE 100

    6,996.08
    -29.35 (-0.42%)
     
  • Nikkei 225

    27,970.22
    +136.93 (+0.49%)
     

Company News for Mar 16, 2021

·1 min read
  • Shares of Rubius Therapeutics, Inc. RUBY surged 84.4% after the company reported initial clinical data from its ongoing Phase 1/2 trial of RTX-240 in patients with advanced solid tumors.

  • Shaw Communications Inc.’s SJR jumped 41.4% after the company announced that it would be acquired by Rogers Communications in a deal worth around $20 billion.

  • Shares of GenMark Diagnostics, Inc. GNMK jumped 29.6% after Roche Holding AG announced plans to acquire the company for $24.05 per share in cash, or about $1.8 billion.

  • RumbleON, Inc.’s RMBL shares rose 47.7% after the company announced that it has entered into a definitive agreement to acquire RideNow at $575.4 million.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Shaw Communications Inc. (SJR) : Free Stock Analysis Report
 
GenMark Diagnostics, Inc. (GNMK) : Free Stock Analysis Report
 
RumbleON, Inc. (RMBL) : Free Stock Analysis Report
 
Rubius Therapeutics, Inc. (RUBY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.